| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.26 | 0.07 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |